ProfileGDS4132 / 225837_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 36% 41% 41% 59% 42% 41% 40% 42% 43% 52% 60% 57% 45% 47% 70% 68% 65% 45% 67% 58% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10190.318936
GSM201543Muscle PCOS pioglitazone 12198.192541
GSM201544Muscle PCOS pioglitazone 161108.95841
GSM201545Muscle PCOS pioglitazone 201172.69859
GSM201829Muscle PCOS pioglitazone 231116.7142
GSM201830Muscle PCOS pioglitazon 251110.341
GSM201831Muscle PCOS pioglitazone 271102.14740
GSM201832Muscle PCOS pioglitazone 31109.17442
GSM201833Muscle PCOS pioglitazone 41105.1843
GSM201834Muscle PCOS pioglitazone 81138.64652
GSM201835Muscle PCOS after pioglitazone 102155.33460
GSM201836Muscle PCOS after pioglitazone 122147.29657
GSM201837Muscle PCOS after pioglitazone 162100.92245
GSM201838Muscle PCOS after pioglitazone 202115.40447
GSM201839Muscle PCOS after pioglitazone 232210.87770
GSM201840Muscle PCOS after pioglitazone 252200.39468
GSM201841Muscle PCOS after pioglitazone 272174.00365
GSM201842Muscle PCOS after pioglitazone 3297.104845
GSM201843Muscle PCOS after pioglitazone 42188.6267
GSM201844Muscle PCOS after pioglitazone 82157.2358